Geoffrey von Maltzahn
Founder · Investor
Now Co-founder and CEO, Lila Sciences; Founder, Generate:Biomedicines; General Partner, Flagship Pioneering
Latest on AI4S.fyiFunding · Jun 3 · founderLila Sciences · Series B · about $2 billion (in talks)Photos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →
Affiliations
Current
- Co-founder and CEO · Lila Sciences
- Founder · Generate:Biomedicines
- General Partner · Flagship Pioneering
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
About
Geoffrey von Maltzahn is a general partner at Flagship Pioneering, which he joined in 2009, and co-founded Generate:Biomedicines there along with companies including Lila Sciences, Tessera Therapeutics, Indigo Agriculture and Sana Biotechnology. He is board chair of Tessera. He was founding CEO of Tessera, Cobalt Biomedicine and Indigo, and earlier chief technology officer of Seres Therapeutics.
Read on 2026-09-29; for current roles see Affiliations above. Read at: flagshippioneering.com ↗
Founded
Generate:BiomedicinesProtein design · 2018 · 3 rounds on record · disclosed $1.04B · IPO $400MBackground: Flagship Pioneering (co-founder) (as the company's own announcements put it)
Co-founders: Noubar Afeyan
Lila SciencesAutonomous labs · 2023 · 4 rounds on record · disclosed $550M · Series B about $2 billionBackground: Flagship Pioneering (General Partner) (as the company's own announcements put it)
Co-founders: Noubar Afeyan, Rafael Gómez-Bombarelli, Alexandra Sneider, Ben Kompa, Molly Gibson
Backed byBraidwellCollective Global
On the timeline
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →